Fluoroquinolone Resistance in Clinical Isolates of Streptococcus pneumoniae from Asian Countries: ANSORP Study

Microbial Drug Resistance

Volumn 10, Issue 1, 2004, Pages 37-42

  Oh, Won Sup ^a   Suh, Ji Yoeun ^b   Song, Jae Hoon ^a,c,m   Ko, Kwan Soo ^c   Jung, Sook In ^d   Peck, Kyong Ran ^a   Lee, Nam Yong ^a   Yang, Yonghong ^e   Chongthaleong, Anan ^f   Chiu, Cheng Hsun ^g   Kamarulzaman, Adeeba ^h   Parasakthi, Navartnam ^h   Lalitha, M K ⁱ   Perera, Jennifer ^j   Yee, Ti Teow ^k   Kumarasinghe, Gamini ^k   Carlos, Celia C ^l  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Samsung Medical Center   (South Korea)

^c Asia Pacific Foundation for Infectious Diseases (APFID)   (South Korea)

^d Chonnam National University Medical School   (South Korea)

^e CAPITAL MEDICAL UNIVERSITY   (China)

^f CHULALONGKORN UNIVERSITY   (Thailand)

^g CHANG GUNG CHILDREN S HOSPITAL   (Taiwan)

^h UNIVERSITY OF MALAYA   (Malaysia)

ⁱ CHRISTIAN MEDICAL COLLEGE   (India)

^j UNIVERSITY OF COLOMBO   (Sri Lanka)

^k NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^l Res Institute of Topical Medicine   (Philippines)

^m Sungkyunkwan University   (South Korea)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; ERYTHROMYCIN; GATIFLOXACIN; LEVOFLOXACIN; MOXIFLOXACIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; ASIAN; BACTERIAL GENE; BACTERIUM ISOLATE; DNA SEQUENCE; GENE MUTATION; GYRA GENE; GYRB GENE; HONG KONG; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; NUCLEOTIDE SEQUENCE; PARC GENE; PARE GENE; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SEROTYPE; STREPTOCOCCUS PNEUMONIAE;

ANTI-BACTERIAL AGENTS; ASIA; CIPROFLOXACIN; DNA GYRASE; DNA TOPOISOMERASE IV; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; FLUOROQUINOLONES; MICROBIAL SENSITIVITY TESTS; PNEUMOCOCCAL INFECTIONS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

BACTERIA (MICROORGANISMS); STREPTOCOCCUS; STREPTOCOCCUS PNEUMONIAE;

EID: 11144356592     PISSN: 10766294     EISSN: None     Source Type: Journal    
DOI: 10.1089/107662904323047781     Document Type: Article

References (33)

1. Alou, L., M. Ramirez, C. García-Rey, J. Prieto, and H. de Lencastre. 2001. Streptococcus pneumoniae isolates with reduced susceptibility to ciprofloxacin in Spain: clonal diversity and appearance of ciprofloxacin-resistant epidemic clones. Antimicrob. Agents Chemother. 45:2955-2957.
2. Balas, D., E. Fernandez-Moreira, and A.G. De La Campa. 1998. Molecular characterization of the gene encoding the DNA gyrase a subunit of Streptococcus pneumoniae. J. Bacteriol. 180:2854-2861.
3. Bast, D.J., D.E. Low, C.L. Duncan, L. Kilburn, L.A. Mandell, R.J. Davidson, and J.C.S. de Azavedo. 2000. Fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae: contributions of type II topoisomerase mutations and efflux to levels of resistance. Antimicrob. Agents Chemother. 44:3049-3054.
4. Brenwald, N.P., M.J. Gill, and R. Wise. 1998. Prevalence of a putative efflux mechanism among fluoroquinolone-resistant clinical isolates of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 42:2032-2035.
5. Brueggemann, A.B., S.L. Coffman, P. Rhomberg, H. Huynh, L. Almer, A. Nilius, R. Flamm, and G.V. Doern. 2002. Fluoroquinolone resistance in Streptococcus pneumoniae in United States since 1994-1995. Antimicrob. Agent Chemother, 46:680-688.
6. Chen, D.K., A. McGeer, J.C. de Azavedo, D.E. Low, and The Canadian Bacterial Surveillance Network. 1999. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. N. Engl. J. Med. 341:233-239.
7. Drlica, K., and X.L. Zhao. 1997. DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiol. Mol. Biol. Rev. 61:377-392.
8. Ferrándiz, M.J., A. Fennoll, J. Linares, and A.G. De La Campa. 2000. Horizontal transfer of parC and gyrA in fluoroquinolone-resistant isolates of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 44:840-847.
9. Gill, M.J., N.P. Brenwald, and R. Wise. 1999. Identification of an efflux pump gene, pmrA, associated with fluoroquinolone resistance in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 43:187-189.
10. Goldsmith, C.E., J.E. Moore, P.G. Murphy, and J.E. Ambler. 1998. Increased incidence of ciprofloxacin resistance in penicillin-resistant pneumococci in Northern Ireland. J. Antimicrob. Chemother. 41:420-421.
11. Ho, P.L., W.C. Yam, T.L. Que, D.N.C. Tsang, W.H. Seto, T.K. Ng, and W.S. Ng. 2001. Target site modifications and efflux phenotype in clinical isolates of Streptococcus pneumoniae from Hong Kong with reduced susceptibility to fluoroquinolones. J. Antimicrob. Chemother. 47:655-658.
12. Ho, P.L., R.W.H. Yung, D.N.C. Tsang, T.L. Que, M. Ho, W.H. Seto, T.K. Ng, W.C. Yam, and W.S. Ng. 2001. Increasing resistance of Streptococcus pneumoniae to fluoroquinolones: results of a Hong Kong multicentre study in 2000. J. Antimicrob. Chemother. 48:659-665.
13. Hooper, D.C. 2000. New uses for new and old quinolones and the challenge of resistance. Clin. Infect. Dis. 30:243-254.
14. Hooper, D.C. 2002. Fluoroquinolone resistance among Gram-positive cocci. Lancet Infect. Dis. 2:530-538.
15. Jacobs, M.R., and P.C. Appelbaum. 1995. Antibiotic-resistant pneumococci. Rev. Med. Microbiol. 6:77-93.
16. Janoir, C., V. Zeller, M.-D. Kitzis, N.J. Moreau, and L. Gutmann. 1996. High-level fluoroquinolone resistance in Streptococcus pneumoniae requires mutations in parC and gyrA. Antimicrob. Agents Chemother. 40:2760-2764.
17. Jones, M.E., D.F. Sahm, N. Martin, S. Scheuring, P. Heisig, C. Thornsberry, K. Köhrer, and F.-J. Schmitz. 2000. Prevalence of gyrA, gyrB, parC, and parE mutations in clinical isolates of Streptococcus pneumoniae with decreased susceptibilities to different fluoroquinolones and originating from worldwide surveillance studies during the 1997-1998 respiratory season. Antimicrob. Agents Chemother. 44:462-466.
18. Jorgensen, J.H., L.M. Weigel, M.J. Ferrado, J.M. Swenson, and F.C. Tenover. 1999. Activities of newer fluoroquinolones against Streptococcus pneumoniae clinical isolates including those with mutations in the gyrA, parC, and parE loci. Antimicrob. Agents Chemother. 43:329-334.
19. Linares, J., A.G. de la Campa, and R. Pallares. 1999. Fluoroquinolone resistance in Streptococcus pneumoniae. N. Engl. J. Med. 341:1546-1547.
20. McGee, L., C.E. Goldsmith, and K.P. Klugman. 2002. Fluoroquinolone resistance among clinical isolates of Streptococcus pneumoniae belonging to international multiresistant clones. J. Antimicrob. Chemother. 49:173-176.
21. National Committee for Clinical Laboratory Standards. 2000. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, fifth ed. Approved standard M7-A5. National Committee for Clinical Laboratory Standard, Villanova, PA.
22. National Committee for Clinical Laboratory Standards. 2001. Performance standards for antimicrobial susceptibility testing; Eleventh informational Supplement M100-S11. National Committee for Clinical Laboratory Standard, Villanova, PA.
23. Pan, X.-S., J. Ambler, S. Mehtar, and L.M. Fisher. 1996. Involvement of Topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae. Antimicrob. Agent Chemother. 40:2321-2326.
24. Pantosi, A., F.D'Ambrosio, A. Tarasi, S. Recchia, G. Orefici, and P. Mastrantoio. 2000. Antibiotic susceptibility and serotype distribution of Streprococcus pneumoniae causing meningitides in Italy, 1997-1999. Clin. Infect. Dis. 31:1373-1379.
25. Perichon, B., J. Tankovic, and P. Courvalin. 1997. Characterization of a mutation in the pare gene that confers fluoroquinolone resistance in Streptococcus pneumoniae. Antimicrob. Agent Chemother, 41:1166-1167.
26. Pestova, E., R. Beyer, N.P. Cianciotto, G.A. Noskin, and L.R. Peterson. 1999. Contribution of topoisomerase IV and DNA gyrase mutations in Streptococcus pneumoniae to resistance to novel fluoroquinolones. Antimicrob. Agents Chemother. 43:2000-2004.
27. Tankovic, J., B. Perichon, J. Duval, and P. Courvalin. 1996. Contribution of mutations in gyrA and parC genes to fluoroquinolone resistance of mutants of Streptococcus pneumoniae obtained in vivo and in vitro. Antimicrob. Agents Chemother. 40:2505-2510.
28. Tenover, F.C., R.E. Arbeit, R.V. Goering, P.A. Mikelsen, B.E. Murray, D.H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial-strain typing. J. Clin. Microbiol. 33:2233-2239.
29. Thompson, J.D., T.J. Gibson, F. Plewniak, F. Jeanmougin, and D.G. Higgin. 1997. The Clustal X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res. 24:4876-4882.
30. Weigel, L.M., G.J. Anderson, R.R. Facklam, and F.C. Tenover. 2001. Genetic analyses of mutations contributing to fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 45:3517-3523.
31. Whitney, C.G., M.M. Farley, J. Hadler, L.H. Harrison, C. Lexau, A. Reingold, L. Lefkowitz, P.R. Cielslak, M. Cetron, E.R. Zell, M. Stat, J.H. Jorgensen, and A. Schuchat. 2000. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. N. Engl. J. Med, 343:1917-1924.
32. Zhanel, G.G., A. Walkty, K. Nichol, H. Smith, A. Noreddin, and D.J. Hoban. 2003. Molecular characterization of fluoroquinolone resistant Streptococcus pneumoniae clinical isolates obtained from across Canada. Diagn. Microbiol. Infect. Dis. 45:63-67.
33. Zheng, X., C. Johnson, Y. Lu, R. Yanagihara, S. Hollingshead, M. Crain, W. Benjamin Jr., and K.B. Waites. 2001. Clinical isolates of Streptococcus pneumoniae resistant to levofloxacin contain mutations in both gyrA and parC genes. Intern. J. Antimicrob. Agents 18:373-378.